Trilaciclib Combined With Immunochemotherapy for R/M HNSCC
8d agoen
From the article
Conditions : Head & Neck Squamous Cell Carcinoma Interventions : Drug: Trilaciclib Sponsors : Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Not yet recruiting
Continue reading on clinicaltrials.gov
Comments
Sign in to join the conversation.
No comments yet. Be the first.